中文简体
返回
下载
登录后咨询在线客服
回到顶部

子公司更新/资讯

$Evogene (EVGN.US)$ Lavie Bio获得以色列创新当局资助,推进“MicroFermentor”技术的开发,这是一项可以改变农业生物经济的独特技术
37分钟前,东部时间上午7:00
通过PR通讯社
该技术旨在降低应用成本,延长货架寿命,并延长田间应用后细菌的存活率
在纳斯达克上市的Evogene Ltd.(纳斯达克: EVGN) (TASE: EVGN), announced receiving a grant from the Israel Innovation Authority (IIA) to advance its program to develop a breakthrough technology for the delivery of ag-biologicals to agriculture. This patented technology, named 'MicroFermentor', is based on an innovative microbe formulation that enables the multiplication of beneficial bacteria directly on the plant, reducing application costs, extending shelf life, and prolonging the bacteria's viability after field application. The grant was awarded following positive initial microbe encapsulation and greenhouse validation experiments and will support the program's next phase of development toward commercialization.
免责声明:社区由Moomoo Technologies Inc.提供,仅用于教育目的。 更多信息
3
+0
原文
举报
浏览 6146
评论
登录发表评论
    5120
    粉丝
    23
    关注
    7.4万
    来访
    关注
    热议
    美股